<!DOCTYPE html>
<html lang="ko">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>내분비내과 신체기능평가(SPPB) 전략 보고서 | AndanteFit</title>
  <meta name="description" content="내분비내과에서 신체기능평가(SPPB)를 활용해 당뇨·비만 환자의 예후를 예측하고 치료의 질을 높이는 전략. GLP-1 치료 모니터링과 근감소성 비만 단계화 임상 가이드 포함.">
  <meta name="robots" content="index, follow">
  <meta name="author" content="DYPHI Inc.">
  <meta name="language" content="ko">
  <meta name="theme-color" content="#0d9488">

  <!-- Canonical & hreflang (EN/ES 페이지 미존재 — ko only) -->
  <link rel="canonical" href="https://andantefit.com/ko/case-studies/2026-02-21-Endocrinology-SPPB-Strategy-KR.html">
  <link rel="alternate" hreflang="ko" href="https://andantefit.com/ko/case-studies/2026-02-21-Endocrinology-SPPB-Strategy-KR.html">

  <!-- Open Graph -->
  <meta property="og:type" content="website">
  <meta property="og:locale" content="ko_KR">
  <meta property="og:site_name" content="AndanteFit">
  <meta property="og:title" content="내분비내과 신체기능평가(SPPB) 전략 보고서 | AndanteFit">
  <meta property="og:description" content="당뇨·비만 환자에서 SPPB가 사망 위험 예측과 GLP-1 치료 모니터링에 어떻게 활용되는지 정리한 임상 전략 보고서입니다.">
  <meta property="og:url" content="https://andantefit.com/ko/case-studies/2026-02-21-Endocrinology-SPPB-Strategy-KR.html">
  <meta property="og:image" content="../../assets/andantefit-logo.png">

  <!-- Twitter Card -->
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="내분비내과 SPPB 전략 보고서 | AndanteFit">
  <meta name="twitter:description" content="당뇨·비만 환자에서 SPPB가 사망 위험 예측과 GLP-1 치료 모니터링에 어떻게 활용되는지 정리합니다.">
  <meta name="twitter:image" content="../../assets/andantefit-logo.png">

  <!-- Medical Meta -->
  <meta name="medical-subject" content="SPPB, Sarcopenic Obesity, Endocrinology, GLP-1, Functional Assessment">
  <meta name="target-audience" content="Endocrinologists, Diabetologists, Clinical Researchers">

  <!-- Schema.org -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "name": "내분비내과 신체기능평가(SPPB) 전략 보고서",
    "description": "당뇨·비만 환자에서 SPPB를 활용한 사망 위험 예측, GLP-1 치료 모니터링, 근감소성 비만 단계화 임상 가이드",
    "inLanguage": "ko",
    "datePublished": "2026-02-21",
    "dateModified": "2026-02-21",
    "url": "https://andantefit.com/ko/case-studies/2026-02-21-Endocrinology-SPPB-Strategy-KR.html",
    "publisher": {
      "@type": "Organization",
      "name": "DYPHI Inc.",
      "url": "https://andantefit.com",
      "logo": {
        "@type": "ImageObject",
        "url": "https://andantefit.com/assets/andantefit-logo.png"
      }
    },
    "audience": {
      "@type": "MedicalAudience",
      "audienceType": ["Endocrinologist", "Diabetologist", "Physician"]
    },
    "citation": [
      { "@type": "ScholarlyArticle", "name": "DCCT/EDIC Research Group. Diabetes Care." },
      { "@type": "ScholarlyArticle", "name": "ESPEN/EASO Consensus Statement, 2022." },
      { "@type": "ScholarlyArticle", "name": "Vaduganathan et al. Ann Intern Med, 2025." }
    ]
  }
  </script>

  <!-- Google Analytics -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-0L4ENVHFYP"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());
    gtag('config', 'G-0L4ENVHFYP');
  </script>

  <!-- Resource Hints -->
  <link rel="preconnect" href="https://cdn.tailwindcss.com">
  <link rel="preconnect" href="https://cdn.jsdelivr.net">

  <!-- AndanteFit Base Stylesheet -->
  <link rel="stylesheet" href="../css/style.css">

  <!-- External Libraries -->
  <script src="https://cdn.tailwindcss.com"></script>
  <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>

  <style>
    /* === Font: Pretendard only === */
    body {
      font-family: Pretendard, -apple-system, BlinkMacSystemFont, system-ui, Segoe UI, Roboto,
        "Apple SD Gothic Neo", Arial, sans-serif;
      background-color: #f8fafc;
      color: #334155;
    }

    /* === Chart Container: min-height (fixed height 금지) === */
    .chart-container {
      position: relative;
      width: 100%;
      max-width: 600px;
      margin-left: auto;
      margin-right: auto;
      min-height: 300px;
    }
    @media (min-width: 768px) {
      .chart-container {
        min-height: 350px;
      }
    }

    /* === Scrollbar === */
    ::-webkit-scrollbar { width: 8px; }
    ::-webkit-scrollbar-track { background: #f1f5f9; }
    ::-webkit-scrollbar-thumb { background: #cbd5e1; border-radius: 4px; }
    ::-webkit-scrollbar-thumb:hover { background: #94a3b8; }

    /* === Tab Styles === */
    .tab-active {
      border-bottom: 2px solid #0f766e;
      color: #0f766e;
      font-weight: 700;
    }
    .tab-inactive {
      border-bottom: 2px solid transparent;
      color: #64748b;
    }
    .tab-inactive:hover {
      color: #334155;
      border-bottom: 2px solid #cbd5e1;
    }

    /* === Card Shadow === */
    .card-shadow {
      box-shadow: 0 4px 6px -1px rgba(0,0,0,0.05), 0 2px 4px -1px rgba(0,0,0,0.03);
    }

    /* === Case Study Entry Header (below site nav) === */
    .case-entry-header {
      background: linear-gradient(135deg, #f0fdfa 0%, #f8fafc 100%);
      border-bottom: 1px solid #e2e8f0;
    }
  </style>
</head>

<body class="antialiased min-h-screen flex flex-col">

  <!-- Site Navigation (injected by navigation.js) -->
  <div id="navigation-container"></div>

  <!-- Page Header -->
  <header class="case-entry-header pt-6 pb-8">
    <div class="max-w-6xl mx-auto px-4 sm:px-6 lg:px-8">
      <div class="flex items-center gap-3 mb-4">
        <div class="w-1 bg-teal-600 rounded-full" style="min-height:2.5rem"></div>
        <div>
          <span class="text-xs font-semibold text-teal-600 uppercase tracking-widest">내분비내과 · AndanteFit 케이스 스터디</span>
          <h1 class="text-2xl font-bold text-slate-800 tracking-tight leading-tight mt-0.5">
            신체기능평가(SPPB) 전략 보고서
          </h1>
          <p class="text-sm text-slate-500 mt-1">당뇨 · 비만 환자에서 기능 중심 진료 패러다임으로의 전환</p>
        </div>
      </div>
      <div class="flex flex-wrap gap-2 mt-2 ml-4">
        <span class="px-2 py-0.5 bg-teal-50 text-teal-700 text-xs font-medium rounded-full border border-teal-100">SPPB</span>
        <span class="px-2 py-0.5 bg-teal-50 text-teal-700 text-xs font-medium rounded-full border border-teal-100">근감소성 비만</span>
        <span class="px-2 py-0.5 bg-teal-50 text-teal-700 text-xs font-medium rounded-full border border-teal-100">GLP-1</span>
        <span class="px-2 py-0.5 bg-teal-50 text-teal-700 text-xs font-medium rounded-full border border-teal-100">2형 당뇨</span>
        <span class="px-2 py-0.5 bg-slate-100 text-slate-500 text-xs font-medium rounded-full">2026-02-21</span>
      </div>
    </div>
  </header>

  <!-- Navigation Tabs -->
  <nav class="bg-white border-b border-slate-200 sticky top-0 z-40 shadow-sm" aria-label="섹션 탭">
    <div class="max-w-6xl mx-auto px-4 sm:px-6 lg:px-8">
      <div class="flex space-x-6 overflow-x-auto">
        <button onclick="switchTab('tab-overview')" id="nav-tab-overview"
          class="tab-active whitespace-nowrap py-4 px-1 text-sm font-medium transition-colors">
          Executive Summary
        </button>
        <button onclick="switchTab('tab-rationale')" id="nav-tab-rationale"
          class="tab-inactive whitespace-nowrap py-4 px-1 text-sm font-medium transition-colors">
          1. 도입 필요성
        </button>
        <button onclick="switchTab('tab-evidence')" id="nav-tab-evidence"
          class="tab-inactive whitespace-nowrap py-4 px-1 text-sm font-medium transition-colors">
          2. 임상 근거
        </button>
        <button onclick="switchTab('tab-therapy')" id="nav-tab-therapy"
          class="tab-inactive whitespace-nowrap py-4 px-1 text-sm font-medium transition-colors">
          3–4. 치료 및 GLP-1
        </button>
        <button onclick="switchTab('tab-guidelines')" id="nav-tab-guidelines"
          class="tab-inactive whitespace-nowrap py-4 px-1 text-sm font-medium transition-colors">
          5. 가이드라인
        </button>
      </div>
    </div>
  </nav>

  <!-- Main Content -->
  <main class="flex-grow bg-slate-50 py-8">
    <div class="max-w-5xl mx-auto px-4 sm:px-6 lg:px-8">

      <!-- TAB 1: EXECUTIVE SUMMARY -->
      <section id="tab-overview" class="tab-content block">
        <div class="bg-white rounded-lg p-8 border-l-4 border-teal-600 card-shadow mb-8">
          <h2 class="text-2xl font-bold text-slate-800 tracking-tight mb-4">진료 패러다임의 전환</h2>
          <p class="text-sm leading-relaxed text-slate-600 mb-6">
            최근 내분비 질환 치료는 단순한 수치(Glucose, BMI) 관리를 넘어
            <span class="bg-teal-50 text-teal-800 font-bold px-1 rounded">체성분의 질적 개선</span>과
            <span class="bg-teal-50 text-teal-800 font-bold px-1 rounded">신체 기능의 보존</span>으로
            그 목표가 확장되고 있습니다.
          </p>
          <div class="grid md:grid-cols-2 gap-6 mt-6 border-t border-slate-100 pt-6">
            <div>
              <span class="block text-xs font-semibold text-slate-400 uppercase tracking-wider mb-1">Current Focus</span>
              <div class="text-sm leading-relaxed text-slate-700 font-medium">단순 체중 감소, 혈당 수치 관리</div>
            </div>
            <div>
              <span class="block text-xs font-semibold text-teal-600 uppercase tracking-wider mb-1">Strategic Shift</span>
              <div class="text-sm leading-relaxed text-slate-900 font-bold flex items-center">
                근육의 질(Muscle Quality) &amp; 기능(Function)
                <span class="ml-2 text-teal-600">&rarr;</span>
              </div>
            </div>
          </div>
        </div>

        <div class="grid md:grid-cols-3 gap-6">
          <div class="bg-white p-6 rounded-lg card-shadow">
            <div class="text-teal-600 text-3xl font-bold tracking-tight mb-2">SPPB</div>
            <h3 class="font-bold text-slate-700 mb-2 text-sm">핵심 평가 도구</h3>
            <p class="text-sm leading-relaxed text-slate-500 mb-4">
              Short Physical Performance Battery는 환자의 예후를 예측하고 치료의 질을 평가하는 실질적 지표입니다.
            </p>
            <a href="2026-02-07-SPPB-Occupational-Health-KR.html"
               class="text-xs text-teal-600 underline underline-offset-2 hover:text-teal-800 font-medium">
              직장 건강에서의 SPPB 활용 사례 보기 &rarr;
            </a>
          </div>
          <div class="bg-white p-6 rounded-lg card-shadow">
            <div class="text-teal-600 text-3xl font-bold tracking-tight mb-2">3x</div>
            <h3 class="font-bold text-slate-700 mb-2 text-sm">사망 위험 예측</h3>
            <p class="text-sm leading-relaxed text-slate-500">
              2형 당뇨 환자에서 SPPB 5점 미만일 경우, 고기능군 대비 사망 위험이 약 3배 이상 높습니다.
            </p>
          </div>
          <div class="bg-white p-6 rounded-lg card-shadow">
            <div class="text-teal-600 text-3xl font-bold tracking-tight mb-2">GLP-1</div>
            <h3 class="font-bold text-slate-700 mb-2 text-sm">치료 목표 확장</h3>
            <p class="text-sm leading-relaxed text-slate-500">
              체중 감소뿐만 아니라 기능 유지 및 개선이 새로운 비만 치료의 평가 기준이 되어야 합니다.
            </p>
          </div>
        </div>
      </section>

      <!-- TAB 2: RATIONALE -->
      <section id="tab-rationale" class="tab-content hidden">
        <div class="mb-6">
          <h2 class="text-2xl font-bold text-slate-800 tracking-tight">Section 1. 왜 신체 기능을 보아야 하는가?</h2>
          <p class="text-sm leading-relaxed text-slate-500 mt-2">
            내분비 진료에서 단순히 BMI와 혈당만으로는 환자의 실제 건강 상태를 파악하는 데 한계가 있습니다. 근육의 '질'에 주목해야 합니다.
          </p>
        </div>
        <div class="space-y-6">
          <!-- Card 1 -->
          <div class="bg-white rounded-lg border border-slate-200 p-6 flex flex-col md:flex-row gap-6 items-start card-shadow">
            <div class="flex-shrink-0 w-12 h-12 bg-rose-100 rounded-full flex items-center justify-center text-rose-600 text-xl font-bold">1</div>
            <div>
              <h3 class="text-base font-bold text-slate-800 tracking-tight mb-2">근육의 질적 저하 (Muscle Quality)</h3>
              <p class="text-sm leading-relaxed text-slate-600 mb-3">
                당뇨병과 비만은 <strong>근육 내 지방 침착(Myosteatosis)</strong> 및 미토콘드리아 기능 저하를 유발합니다.
              </p>
              <div class="bg-slate-50 p-4 rounded text-sm leading-relaxed text-slate-500">
                <strong>Impact:</strong> 근육의 양이 같더라도, 질이 떨어지면 실제 신체 수행 능력(Performance)은 현저히 낮아집니다.
              </div>
            </div>
          </div>
          <!-- Card 2 -->
          <div class="bg-white rounded-lg border border-slate-200 p-6 flex flex-col md:flex-row gap-6 items-start card-shadow">
            <div class="flex-shrink-0 w-12 h-12 bg-amber-100 rounded-full flex items-center justify-center text-amber-600 text-xl font-bold">2</div>
            <div>
              <h3 class="text-base font-bold text-slate-800 tracking-tight mb-2">BMI의 한계와 체성분 불균형</h3>
              <p class="text-sm leading-relaxed text-slate-600 mb-3">
                고령 환자에게 BMI는 신체 기능을 예측하는 데 부정확할 수 있습니다.
                <strong>제지방량/지방량(FFM/FM) 비율</strong>이 더 중요한 지표입니다.
              </p>
              <div class="bg-slate-50 p-4 rounded text-sm leading-relaxed text-slate-500">
                <strong>Role of SPPB:</strong> 체성분의 불균형이 실제 생활에서 '걷기', '일어서기' 등 기능적 제한으로 나타나는지를 평가합니다.
              </div>
            </div>
          </div>
          <!-- Card 3 -->
          <div class="bg-white rounded-lg border border-slate-200 p-6 flex flex-col md:flex-row gap-6 items-start card-shadow">
            <div class="flex-shrink-0 w-12 h-12 bg-blue-100 rounded-full flex items-center justify-center text-blue-600 text-xl font-bold">3</div>
            <div>
              <h3 class="text-base font-bold text-slate-800 tracking-tight mb-2">독립적인 예후 예측 지표</h3>
              <p class="text-sm leading-relaxed text-slate-600 mb-3">
                SPPB 점수는 단순한 운동 능력 점수가 아닙니다. 사망률, 입원, 심혈관 사건을 독립적으로 예측합니다.
              </p>
              <div class="flex gap-2 flex-wrap">
                <span class="px-3 py-1 bg-blue-50 text-blue-700 text-xs font-semibold rounded-full">사망률 연관</span>
                <span class="px-3 py-1 bg-blue-50 text-blue-700 text-xs font-semibold rounded-full">입원 위험 예측</span>
                <span class="px-3 py-1 bg-blue-50 text-blue-700 text-xs font-semibold rounded-full">심혈관 사건 독립 지표</span>
              </div>
            </div>
          </div>
        </div>
      </section>

      <!-- TAB 3: EVIDENCE -->
      <section id="tab-evidence" class="tab-content hidden">
        <div class="mb-6">
          <h2 class="text-2xl font-bold text-slate-800 tracking-tight">Section 2. 당뇨병 환자에서의 근거</h2>
          <p class="text-sm leading-relaxed text-slate-500 mt-2">
            1형 및 2형 당뇨병 환자 모두에서 신체 기능 저하는 주요 합병증 및 사망률과 직결됩니다.
          </p>
        </div>
        <div class="grid lg:grid-cols-2 gap-8">
          <!-- Chart: T2D Mortality -->
          <div class="bg-white p-6 rounded-lg card-shadow">
            <h3 class="text-base font-bold text-slate-800 tracking-tight mb-4 border-b border-slate-100 pb-2">
              2형 당뇨: SPPB 점수와 사망 위험도
            </h3>
            <p class="text-sm leading-relaxed text-slate-500 mb-4">
              SPPB 점수가 낮을수록(기능이 떨어질수록) 사망 위험도가 급격히 상승합니다.
              <br><span class="text-xs text-slate-400">*이탈리아 코호트 연구 기반 데이터 시각화</span>
            </p>
            <div class="chart-container">
              <canvas id="mortalityChart"></canvas>
            </div>
            <div class="mt-4 bg-rose-50 border border-rose-100 p-3 rounded text-sm leading-relaxed text-rose-700">
              <strong>Warning:</strong> SPPB 5점 미만 환자군은 고기능군 대비 약 3배 이상의 사망 위험을 보입니다.
            </div>
          </div>
          <!-- T1D Text Content -->
          <div class="bg-white p-6 rounded-lg card-shadow flex flex-col justify-between">
            <div>
              <h3 class="text-base font-bold text-slate-800 tracking-tight mb-4 border-b border-slate-100 pb-2">
                1형 당뇨: EDIC 연구 결과
              </h3>
              <div class="space-y-6">
                <div>
                  <div class="text-4xl font-bold text-teal-600 tracking-tight mb-1">21%</div>
                  <p class="text-sm font-medium text-slate-700">기능 제한 환자 비율</p>
                  <p class="text-sm leading-relaxed text-slate-500 mt-1">
                    평균 연령 약 60세의 장기 생존 환자 5명 중 1명은 SPPB 10점 미만의 기능 저하를 보입니다.
                  </p>
                </div>
                <div class="bg-slate-50 p-4 rounded border-l-4 border-teal-500">
                  <h4 class="font-bold text-sm text-slate-700 mb-1">HbA1c와의 상관관계</h4>
                  <p class="text-sm leading-relaxed text-slate-600">
                    혈당 조절이 불량할수록(높은 HbA1c), 신체 기능 점수(SPPB)는 선형적으로 감소하는 경향이 확인되었습니다.
                  </p>
                </div>
              </div>
            </div>
            <div class="mt-6 text-right">
              <span class="text-xs text-slate-400 font-mono">Reference: DCCT/EDIC Research Group</span>
            </div>
          </div>
        </div>
      </section>

      <!-- TAB 4: THERAPY & GLP-1 -->
      <section id="tab-therapy" class="tab-content hidden">
        <div class="mb-6">
          <h2 class="text-2xl font-bold text-slate-800 tracking-tight">Section 3 &amp; 4. 체중 감량과 GLP-1 치료</h2>
          <p class="text-sm leading-relaxed text-slate-500 mt-2">
            단순한 체중 감량은 위험할 수 있습니다. '무엇이 빠지는가'를 모니터링해야 합니다.
          </p>
        </div>

        <!-- Simulation Widget -->
        <div class="bg-white p-6 rounded-lg card-shadow mb-8">
          <div class="flex flex-col md:flex-row justify-between items-center mb-6">
            <h3 class="text-base font-bold text-slate-800 tracking-tight">체중 감량의 질(Quality of Weight Loss) 시뮬레이션</h3>
            <div class="flex bg-slate-100 rounded-lg p-1 mt-4 md:mt-0">
              <button id="btn-diet-only" onclick="updateLossChart('diet')"
                class="px-4 py-2 rounded-md text-sm font-bold bg-white text-slate-800 shadow-sm transition-all">
                식이 조절 Only
              </button>
              <button id="btn-diet-exercise" onclick="updateLossChart('exercise')"
                class="px-4 py-2 rounded-md text-sm font-medium text-slate-500 hover:text-slate-700 transition-all">
                식이 + 운동/단백질
              </button>
            </div>
          </div>
          <div class="grid md:grid-cols-2 gap-8 items-center">
            <div class="chart-container">
              <canvas id="weightLossChart"></canvas>
            </div>
            <div>
              <div id="simulation-text" class="space-y-4">
                <h4 class="text-lg font-bold text-rose-600 tracking-tight">제지방량(근육) 손실 위험</h4>
                <p class="text-sm leading-relaxed text-slate-600">
                  식이 조절만으로 체중을 감량할 경우, 감량된 체중의 상당 부분이 <strong>근육(제지방량) 손실</strong>일 수 있습니다.
                </p>
                <ul class="space-y-2 text-sm leading-relaxed text-slate-500">
                  <li class="flex items-center">
                    <span class="w-2 h-2 bg-rose-500 rounded-full mr-2 flex-shrink-0"></span>하체 근력 감소 우려
                  </li>
                  <li class="flex items-center">
                    <span class="w-2 h-2 bg-rose-500 rounded-full mr-2 flex-shrink-0"></span>SPPB 점수 정체 또는 하락 가능성
                  </li>
                </ul>
              </div>
            </div>
          </div>
        </div>

        <!-- GLP-1 Section -->
        <div class="bg-gradient-to-r from-teal-50 to-white border border-teal-100 rounded-lg p-6">
          <div class="flex items-start gap-4">
            <div class="bg-teal-100 p-2 rounded text-teal-700 text-2xl flex-shrink-0">&#9889;</div>
            <div>
              <h3 class="text-base font-bold text-teal-800 tracking-tight mb-2">GLP-1 치료 시 주의사항</h3>
              <p class="text-sm leading-relaxed text-slate-700 mb-4">
                Semaglutide 등 GLP-1 수용체 작용제 사용 시, 감량된 체중의 일부가 제지방량 감소에서 기인할 수 있다는
                메타분석 결과가 있습니다.
              </p>
              <div class="grid md:grid-cols-2 gap-4">
                <div class="bg-white p-4 rounded border border-teal-100">
                  <strong class="block text-teal-700 text-sm mb-1">임상적 목표 수정</strong>
                  <p class="text-xs leading-relaxed text-slate-600">
                    기존: 체중 감소(Weight Loss)<br>
                    &rarr; 변경: 기능 유지(Functional Maintenance)
                  </p>
                </div>
                <div class="bg-white p-4 rounded border border-teal-100">
                  <strong class="block text-teal-700 text-sm mb-1">임상적 유의 기준 (MCID)</strong>
                  <p class="text-xs leading-relaxed text-slate-600">
                    SPPB 점수 <strong>0.5점 이상</strong>의 변화가 관찰되어야 유의미한 기능 개선으로 봅니다.
                  </p>
                </div>
              </div>
              <div class="mt-4 text-xs text-slate-400">
                * 진행 중 연구: NCT05786521 (GLP-1 + Lifestyle 중재와 SPPB 변화)
              </div>
            </div>
          </div>
        </div>
      </section>

      <!-- TAB 5: GUIDELINES -->
      <section id="tab-guidelines" class="tab-content hidden">
        <div class="mb-6">
          <h2 class="text-2xl font-bold text-slate-800 tracking-tight">Section 5. 근감소성 비만(Sarcopenic Obesity) 단계화</h2>
          <p class="text-sm leading-relaxed text-slate-500 mt-2">
            2022 ESPEN/EASO 합의안에 따른 기능 중심의 분류 체계입니다.
          </p>
        </div>
        <div class="bg-white p-8 rounded-lg card-shadow">
          <div class="flex flex-col items-center">
            <!-- Step 1 -->
            <div class="w-full max-w-lg bg-slate-50 border border-slate-200 rounded-lg p-4 text-center">
              <div class="font-bold text-sm text-slate-700">비만 환자 (Obesity)</div>
              <div class="text-xs text-slate-500 mt-0.5">BMI 또는 허리둘레 기준 충족</div>
            </div>
            <!-- Arrow -->
            <div class="h-8 w-0.5 bg-slate-300 my-1"></div>
            <div class="text-xs text-slate-400 mb-1">근육량/기능 평가</div>
            <!-- Stage Cards -->
            <div class="w-full max-w-lg grid grid-cols-2 gap-4">
              <div class="bg-green-50 border border-green-200 rounded-lg p-4 flex flex-col items-center justify-center text-center">
                <div class="font-bold text-sm text-green-800 mb-2">Stage I</div>
                <div class="text-sm text-slate-600">체성분 변화 O</div>
                <div class="text-sm font-bold text-slate-600">기능 저하 X</div>
                <div class="mt-2 text-xs bg-white px-2 py-1 rounded border border-green-100">SPPB 정상 범위</div>
              </div>
              <div class="bg-rose-50 border border-rose-200 rounded-lg p-4 flex flex-col items-center justify-center text-center relative overflow-hidden">
                <div class="absolute top-0 right-0 bg-rose-500 text-white text-[10px] px-2 py-0.5 font-bold">주의</div>
                <div class="font-bold text-sm text-rose-800 mb-2">Stage II</div>
                <div class="text-sm text-slate-600">체성분 변화 O</div>
                <div class="text-sm font-bold text-slate-600">기능 저하 O</div>
                <div class="mt-2 text-xs bg-white px-2 py-1 rounded border border-rose-100 font-bold text-rose-600">SPPB 점수 저하</div>
              </div>
            </div>
            <!-- Insight Box: dark background uses text-slate-300 -->
            <div class="mt-8 w-full max-w-2xl bg-slate-800 text-slate-300 p-6 rounded-lg">
              <h4 class="font-bold text-sm text-teal-400 tracking-tight mb-2">임상적 적용 포인트</h4>
              <p class="text-sm leading-relaxed">
                비만 치료 시 단순히 체중을 줄이는 것이 아니라, 환자가 <strong class="text-white">Stage I(기능 유지)</strong> 상태인지
                <strong class="text-white">Stage II(기능 저하 동반)</strong> 상태인지를 SPPB로 선별해야 합니다.
                Stage II 환자군에게는 더욱 적극적인 근력 운동 처방과 단백질 섭취가 필수적입니다.
              </p>
            </div>
          </div>
        </div>
      </section>

    </div>
  </main>

  <!-- Footer -->
  <footer class="bg-slate-900 py-12 mt-auto">
    <div class="max-w-6xl mx-auto px-4 sm:px-6 lg:px-8">
      <div class="grid md:grid-cols-2 gap-8">
        <div>
          <h5 class="text-white font-bold mb-4 text-sm">Reference Sites (내분비내과)</h5>
          <ul class="space-y-2 text-sm leading-relaxed text-slate-300">
            <li>• 고려대학교 안산병원 / 안암병원</li>
            <li>• 연세대학교 세브란스병원 / 용인세브란스병원</li>
            <li>• 가톨릭대학교 서울성모병원 / 부천성모병원</li>
            <li>• 분당서울대 / 인하대 / 아주대 / 충남대 / 화순전남대병원</li>
            <li>• 대전엔도내과의원 등 분과 전문 클리닉</li>
          </ul>
        </div>
        <div>
          <h5 class="text-white font-bold mb-4 text-sm">Key Bibliography</h5>
          <ul class="space-y-2 text-xs text-slate-400">
            <li>1. RehabMeasures Database. MCID for SPPB in older adults.</li>
            <li>2. Diabetes &amp; Metabolism Journal, 2023. Muscle quality and T2D.</li>
            <li>3. DCCT/EDIC Research Group. Diabetes Care.</li>
            <li>4. ESPEN/EASO Consensus Statement, 2022.</li>
            <li>5. Vaduganathan et al. Ann Intern Med, 2025.</li>
          </ul>
        </div>
      </div>
      <div class="border-t border-slate-800 mt-8 pt-8 text-center text-xs text-slate-400">
        &copy; 2026 AndanteFit &mdash; DYPHI Inc. All rights reserved.
      </div>
    </div>
  </footer>

  <script>
    /* === Tab Navigation === */
    function switchTab(tabId) {
      document.querySelectorAll('.tab-content').forEach(function(el) {
        el.classList.add('hidden');
        el.classList.remove('block');
      });
      var selected = document.getElementById(tabId);
      if (selected) {
        selected.classList.remove('hidden');
        selected.classList.add('block');
      }
      document.querySelectorAll('button[id^="nav-"]').forEach(function(btn) {
        btn.classList.remove('tab-active');
        btn.classList.add('tab-inactive');
      });
      var activeBtn = document.getElementById('nav-' + tabId.replace('tab-', ''));
      if (activeBtn) {
        activeBtn.classList.remove('tab-inactive');
        activeBtn.classList.add('tab-active');
      }
      if (tabId === 'tab-evidence' && mortalityChart) mortalityChart.resize();
      if (tabId === 'tab-therapy' && lossChart) lossChart.resize();
    }

    /* === Chart 1: Mortality Risk (Evidence) === */
    var mortalityChart;
    function initMortalityChart() {
      var ctx = document.getElementById('mortalityChart').getContext('2d');
      mortalityChart = new Chart(ctx, {
        type: 'bar',
        data: {
          labels: ['고기능군 (SPPB \u226510)', '중등도 기능 (SPPB 6\u20139)', '저기능군 (SPPB \u22645)'],
          datasets: [{
            label: '사망 위험도 (Hazard Ratio)',
            data: [1.0, 1.8, 3.2],
            backgroundColor: ['#cbd5e1', '#fbbf24', '#f43f5e'],
            borderWidth: 0,
            borderRadius: 4
          }]
        },
        options: {
          responsive: true,
          maintainAspectRatio: false,
          plugins: {
            legend: { display: false },
            tooltip: {
              callbacks: {
                label: function(ctx) {
                  return '위험도: 기준 대비 ' + ctx.raw + '배';
                }
              }
            }
          },
          scales: {
            y: {
              beginAtZero: true,
              title: { display: true, text: '사망 위험 비율 (HR)' },
              grid: { color: '#f1f5f9' }
            },
            x: { grid: { display: false } }
          }
        }
      });
    }

    /* === Chart 2: Weight Loss Quality (Therapy) === */
    var lossChart;
    var lossData = {
      diet:     { fat: -6.5, lean: -3.5 },
      exercise: { fat: -8.5, lean: -1.5 }
    };

    function initLossChart() {
      var ctx = document.getElementById('weightLossChart').getContext('2d');
      lossChart = new Chart(ctx, {
        type: 'bar',
        data: {
          labels: ['\uccb4\uc911 \uac10\ub7c9 \uad6c\uc131 (\u221210kg \uac00\uc815)'],
          datasets: [
            {
              label: '\uc9c0\ubc29\ub7c9 \uac10\uc18c (Fat Mass)',
              data: [lossData.diet.fat],
              backgroundColor: '#fbbf24',
              stack: 'Stack 0'
            },
            {
              label: '\uc81c\uc9c0\ubc29\ub7c9 \uac10\uc18c (Lean Mass)',
              data: [lossData.diet.lean],
              backgroundColor: '#f43f5e',
              stack: 'Stack 0'
            }
          ]
        },
        options: {
          responsive: true,
          maintainAspectRatio: false,
          indexAxis: 'y',
          plugins: {
            legend: { position: 'bottom' },
            tooltip: {
              callbacks: {
                label: function(ctx) {
                  return ctx.dataset.label + ': ' + ctx.raw + 'kg';
                }
              }
            }
          },
          scales: {
            x: {
              beginAtZero: true,
              max: 0,
              min: -12,
              title: { display: true, text: '\uac10\ub7c9 (kg)' }
            }
          }
        }
      });
    }

    function updateLossChart(mode) {
      var btnDiet = document.getElementById('btn-diet-only');
      var btnEx   = document.getElementById('btn-diet-exercise');
      var txtDiv  = document.getElementById('simulation-text');

      if (mode === 'diet') {
        btnDiet.className = 'px-4 py-2 rounded-md text-sm font-bold bg-white text-slate-800 shadow-sm transition-all';
        btnEx.className   = 'px-4 py-2 rounded-md text-sm font-medium text-slate-500 hover:text-slate-700 transition-all';
        lossChart.data.datasets[0].data = [lossData.diet.fat];
        lossChart.data.datasets[1].data = [lossData.diet.lean];
        lossChart.data.datasets[1].backgroundColor = '#f43f5e';
        txtDiv.innerHTML =
          '<h4 class="text-lg font-bold text-rose-600 tracking-tight">\uc81c\uc9c0\ubc29\ub7c9(\uadfc\uc721) \uc190\uc2e4 \uc704\ud5d8</h4>' +
          '<p class="text-sm leading-relaxed text-slate-600">\uc2dd\uc774 \uc870\uc808\ub9cc\uc73c\ub85c \uccb4\uc911\uc744 \uac10\ub7c9\ud560 \uacbd\uc6b0, \uac10\ub7c9\ub41c \uccb4\uc911\uc758 \uc0c1\ub2f9 \ubd80\ubd84\uc774 <strong>\uadfc\uc721(\uc81c\uc9c0\ubc29\ub7c9) \uc190\uc2e4</strong>\uc77c \uc218 \uc788\uc2b5\ub2c8\ub2e4.</p>' +
          '<ul class="space-y-2 text-sm leading-relaxed text-slate-500">' +
          '<li class="flex items-center"><span class="w-2 h-2 bg-rose-500 rounded-full mr-2 flex-shrink-0"></span>\ud558\uccb4 \uadfc\ub825 \uac10\uc18c \uc6b0\ub824</li>' +
          '<li class="flex items-center"><span class="w-2 h-2 bg-rose-500 rounded-full mr-2 flex-shrink-0"></span>SPPB \uc810\uc218 \uc815\uccb4 \ub610\ub294 \ud558\ub77d \uac00\ub2a5\uc131</li>' +
          '</ul>';
      } else {
        btnEx.className   = 'px-4 py-2 rounded-md text-sm font-bold bg-white text-teal-700 shadow-sm transition-all';
        btnDiet.className = 'px-4 py-2 rounded-md text-sm font-medium text-slate-500 hover:text-slate-700 transition-all';
        lossChart.data.datasets[0].data = [lossData.exercise.fat];
        lossChart.data.datasets[1].data = [lossData.exercise.lean];
        lossChart.data.datasets[1].backgroundColor = '#94a3b8';
        txtDiv.innerHTML =
          '<h4 class="text-lg font-bold text-teal-600 tracking-tight">\uadfc\uc721 \ubcf4\uc874 \ubc0f \uae30\ub2a5 \uac1c\uc120</h4>' +
          '<p class="text-sm leading-relaxed text-slate-600">\uc6b4\ub3d9\uacfc \ub2e8\ubc31\uc9c8 \uc12d\ucde8\ub97c \ubcd1\ud589\ud558\uba74 <strong>\uc9c0\ubc29 \uc704\uc8fc\uc758 \uac10\ub7c9</strong>\uc774 \uac00\ub2a5\ud558\uba70, SPPB \uc810\uc218\uc758 \uac1c\uc120\uc774 \uad00\ucc30\ub429\ub2c8\ub2e4.</p>' +
          '<ul class="space-y-2 text-sm leading-relaxed text-slate-500">' +
          '<li class="flex items-center"><span class="w-2 h-2 bg-teal-500 rounded-full mr-2 flex-shrink-0"></span>\uadfc\uc721\ub7c9 \ucd5c\ub300\ud55c \ubcf4\uc874</li>' +
          '<li class="flex items-center"><span class="w-2 h-2 bg-teal-500 rounded-full mr-2 flex-shrink-0"></span>SPPB \uc810\uc218 \uac1c\uc120 \uae30\ub300</li>' +
          '</ul>';
      }
      lossChart.update();
    }

    /* === Initialization === */
    document.addEventListener('DOMContentLoaded', function() {
      initMortalityChart();
      initLossChart();
    });
  </script>

  <!-- Site Scripts -->
  <script src="../../js/main.js"></script>
  <script src="../../js/navigation.js"></script>

</body>
</html>
